These lovely three! #uk ❤️ #CROI2024

Presented groundbreaking research on HIV prevention at #CROI2024 in Denver, Colorado. Randomized trial of the SEARCH Dynamic Choice Prevention including injectable cabotegravir (CAB-LA). Injecting hope into the fight against HIV/AIDS. #Research #HIVprevention

Such powerful plenaries and sessions - here, using UNAIDS data to ensure long-acting solutions also reach children. #CROI2024

Attending #CROI2024 my insights: Exciting news on #DVR and #OralPrEP making HIV prevention during pregnancy more inclusive. Also, exploring #DoxyPEP as a significant STI prevention option, eager to bring this research to vulnerable communities in Tanzania. #ResearchAdvocacyTz

We surveyed LGBT+ folks across the US last year, prior to CDC #doxyPEP draft guidelines: 95%(!) were interested in using antibiotics to prevent STIs and 13% recently used doxyPEP. Concerns & motivations for doxyPEP use and contexts where it was used varied. Our #CROI2024 poster:

Who doesn’t love a family photo ? Especially with a great scientific family!
#DARE family dinner 🍴 #CROI2024

It was an honor to deliver the Martin Delaney Lecture 2024 #CROI2024

Powerful words from Dr Dr. Frank Mugisha #CROI2024 - If homosexuality is un-African, why is there a word for it in every language, predating colonialism?

The best part of attending conferences is getting to know like-minded people with similar goals, network and make friends all around the world! Leaving #CROI2024 feeling happy, refreshed and anxious to come back!
(Also, I AM FINALLY IN A GROUP PIC! From our lil UK & Ireland crew)

Future hiv specialist? No pressure! #croi2024

In those who previously experienced challenges with daily oral regiments, long-acting, injectable antiretroviral therapy (ART) suppressed HIV replication and was safe in adolescents per 2 studies at #CROI2024

niaid.nih.gov/news-events/lo…

Generics of Cabotegravir PrEP is available 2027 BUT “We must have parallel scientific discovery and regulatory efforts for earlier and shorter timelines for generic product access!!” ✊ #CROI2024

And still I hear providers saying that patient does not meet criteria for HIV PrEP even when patient ask for it. This must evolve and we should make it accessible, easy to get and cost FREE for everyone. #CROI2024

Un abstract en el #CROI2024 reportó 5 casos de trasmisión del #VIH durante los llamados 'vampire facials' que consisten en inyectar plasma rico en plaquetas con microagujas en la cara. Eran agujas no estériles en un #spa sin los permisos correspondientes en 🇺🇸

Most exciting result of #CROI2024 - long-acting CAB/RPV non-inferior to oral treatment in African public health approach despite high rates of archived drug resistance, subtype A1 virus & BMI>30. LA improved satisfaction. >50% female. Congratulations Cissy Kityo & the CARES team

We're pleased to see that #CROI2024 is calling for abstracts and presentations to adhere to people-first language guidelines.

🌐 Join us in advocating and actively using language that puts people first!
#PutPeopleFirst #HIVLanguageMatters

iasociety.org/language-matte…

After a very busy and tiring but very enjoyable #CROI2024 , i had a very pleasant breakfast and morning chat with dear Adam, where we talked about his and my future plans, our community and the future of the global #HIV movement.

It's really special +

Londonpatient_ HOPE

Dogma dies hard! New approaches for HIV prevention are as important as new products. On demand Oral PrEP fits product use into people’s lives #CROI2024 . Thanks to Jenell Stewart for her fabulous presentation.

LATTITUDE is timely & important but has superiority been called prematurely? The 20% of those who discontinued LA treatment may go onto acquire resistance over the next year due to long PK tail. Long term outcomes really important to fully understand risks vs benefits #CROI2024

Visit poster 530 now to find out more on viral resuppression rates after analytical treatment interruption. 📝

#CROI2024